CAS:158562-40-4|1,3,5,7-tetrakis(4-aminofenyl)adamantan
Molekylformel: C34H36N4
Molekylvekt: 500,68 g/mol
Renhet: 98 prosent
Pakke: 5g/10g/25g/50g/bulkpakke
Transport: FeDex/DHL/Sjøfart/Kundekrav
- Verdensomspennende levering
- Kvalitetssikring
- 24/7 kundeservice
produkt introduksjon
Spesifikasjon
ARTIKLER | SPESIFIKASJON |
CAS: | 158562-40-4 |
Navn | 1,3,5,7-tetrakis(4-aminofenyl)adamantan |
Molekylær formel | C34H36N4 |
Molekylær vekt | 500,68 g/mol |
IUPAC-navn | 4-[3,5,7-tris(4-aminofenyl)-1-adamantyl]anilin |
MDL-nr | MFCD30187657 |
Løselighet | Løselig i DCM, DMF, DMSO |
Lagringsforhold | Oppbevares på mørkt sted, inert atmosfære, romtemperatur |
InChI | InChI=1S/C34H36N4/c35-27-9-1-23(2-10-27)31-17-32(24-3-11-28(36)12-4-24)20-33({ {11}},25-5-13-29(37)14-6-25)22-34(19-31,21-32)26-7-15-30(38)16-8-26 /h1-16H,17-22,35-38H2 |
InChIKey | DVSXMGWZXIYBEJ-UHFFFAOYSA-N |

Populære tags: cas:158562-40-4|1,3,5,7-tetrakis(4-aminofenyl)adamantan, pris, tilbud, rabatt, på lager, til salgs
Du kommer kanskje også til å like
-
![CAS 1203707-77-0|4,4'-(benzo[c][1,2,5]tiadiazol-4,7-diyl)dianilin](/uploads/202235855/small/cas-1203707-77-0-4-4-benzo-c-1-2-509458781282.png?size=384x0)
CAS 1203707-77-0|4,4'-(benzo[c][1,2,5]tiadiazol-4,7-...
-

CAS 25510-41-2|DILITHIUM FTALOCYANIN
-
![CAS:201734-76-1|3'-(3,5-diformylfenyl)-[1,1'-bifenyl]-3,5-dikarbaldehyd](/uploads/202235855/small/cas-201734-76-1-3-3-5-diformylphenyl-1-1a43245783231.jpg?size=384x0)
CAS:201734-76-1|3'-(3,5-diformylfenyl)-[1,1'-bifenyl...
-
![CAS:2607105-89-3|N4,N4-bis(4'-amino-[1,1'-bifenyl]-4-yl)-[1,1'-bifenyl]-4,4'-diamin](/uploads/202235855/small/cas-2607105-89-3-n4-n4-bis-4-amino-1-1a26545094502.jpg?size=384x0)
CAS:2607105-89-3|N4,N4-bis(4'-amino-[1,1'-bifenyl]-4...
-
![CAS:2459652-59-4|[1,1':4',1'':4'',1'''-Quaterphenyl]-3,3''',5,5'''-tetrakarbaldehyd](/uploads/202235855/small/cas-2459652-59-4-1-1-4-1-4-1-quaterphenyl-3a16246922933.jpg?size=384x0)
CAS:2459652-59-4|[1,1':4',1'':4'',1'''-Quaterphenyl]...
-

CAS:1023289-13-5|N2,N4,N6-tri(2H-tetrazol-5-yl)-1,3,...



